Trials / Unknown
UnknownNCT03726814
A Clinical Study of iEPC Intervent Subjects With Cerebral Hemorrhagic Stroke
A Safety and Efficacy Study of Human Peripheral Blood Derived Induced EPCs for Cerebral Hemorrhagic Stroke
- Status
- Unknown
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Allife Medical Science and Technology Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a single centre、single arm、open-label，to investigate the safety and efficacy of EPC transplantation in the brain
Detailed description
The purpose of this study is to evaluate the efficacy and safety of transplantation EPCs intervent subjests with cerebral hemorrhagic stroke.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | EPC treatment group | Brain injection EPC |
Timeline
- Start date
- 2018-12-01
- Primary completion
- 2018-12-01
- Completion
- 2020-12-01
- First posted
- 2018-11-01
- Last updated
- 2018-11-01
Source: ClinicalTrials.gov record NCT03726814. Inclusion in this directory is not an endorsement.